Skip to main content
Year archive

KAINOS MEDICINE, INC. — 2021 filings

All 36 regulatory filings released by KAINOS MEDICINE, INC. (284620) in 2021, sourced directly from the official regulator.

36 Filings
2021 Period
2021 filings (36)
Filing Released Lang
본점소재지변경
Regulatory Filings
2021-12-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2021-12-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-11-19 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-15 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2021-11-12 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change
2021-11-12 Korean
투자판단관련주요경영사항(다계통위축증(MSA) 치료제 KM819의 2상 임상시험 계획 신청 승인)
Regulatory Filings
2021-10-22 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2021-10-14 Korean
투자판단관련주요경영사항(뇌질환치료제 후보물질(KM819) 기술이전 계약 체결)
M&A Activity
2021-09-27 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-08-18 Korean
[기재정정]파생상품거래손실발생
Capital/Financing Update
2021-08-17 Korean
파생상품거래손실발생
Capital/Financing Update
2021-08-13 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-08-12 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-15 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-28 Korean
투자판단관련주요경영사항(다계통위축증(MSA) 치료제 KM819의 2상 임상시험 계획 신청)
Legal Proceedings Report
2021-04-27 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-31 Korean
전환가액의조정(제2회차)
Capital/Financing Update
2021-03-30 Korean
사업보고서 (2020.12)
Audit Report / Information FY 2020
2021-03-23 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-23 Korean
주주총회소집공고
AGM Information
2021-03-16 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-03-15 Korean
[기재정정]감사보고서제출(피합병소멸법인의 2019년도 재발행)
Audit Report / Information FY 2019
2021-03-09 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-02-26 Korean
주주총회소집결의
AGM Information
2021-02-26 Korean
주주총회집중일개최사유신고
AGM Information
2021-02-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-02-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-02-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-02-05 Korean
주요사항보고서(타법인주식및출자증권양도결정)
M&A Activity
2021-02-05 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-01-18 Korean